Cargando…

ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients

OBJECTIVE: The aim of this study was to correlate specific fatty acid profiles of visceral white adipose tissue (WAT) with inflammatory signatures potentially associated with colorectal cancer (CRC). METHODS: Human adipocytes were isolated from biopsies of visceral WAT from 24 subjects subdivided in...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Archivio, Massimo, Scazzocchio, Beatrice, Giammarioli, Stefania, Fiani, Maria L., Varì, Rosaria, Santangelo, Carmela, Veneziani, Augusto, Iacovelli, Annunziata, Giovannini, Claudio, Gessani, Sandra, Masella, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792028/
https://www.ncbi.nlm.nih.gov/pubmed/24116229
http://dx.doi.org/10.1371/journal.pone.0077432
_version_ 1782286787612246016
author D’Archivio, Massimo
Scazzocchio, Beatrice
Giammarioli, Stefania
Fiani, Maria L.
Varì, Rosaria
Santangelo, Carmela
Veneziani, Augusto
Iacovelli, Annunziata
Giovannini, Claudio
Gessani, Sandra
Masella, Roberta
author_facet D’Archivio, Massimo
Scazzocchio, Beatrice
Giammarioli, Stefania
Fiani, Maria L.
Varì, Rosaria
Santangelo, Carmela
Veneziani, Augusto
Iacovelli, Annunziata
Giovannini, Claudio
Gessani, Sandra
Masella, Roberta
author_sort D’Archivio, Massimo
collection PubMed
description OBJECTIVE: The aim of this study was to correlate specific fatty acid profiles of visceral white adipose tissue (WAT) with inflammatory signatures potentially associated with colorectal cancer (CRC). METHODS: Human adipocytes were isolated from biopsies of visceral WAT from 24 subjects subdivided in four groups: normal-weight (BMI 22.0-24.9 Kg/m(2)) and over-weight/obese (BMI 26.0-40.0 Kg/m(2)), affected or not by CRC. To define whether obesity and/or CRC affect the inflammatory status of WAT, the activation of the pro-inflammatory STAT3 and the anti-inflammatory PPARγ transcription factors as well as the expression of adiponectin were analyzed by immunoblotting in adipocytes isolated from each group of subjects. Furthermore, to evaluate whether differences in inflammatory WAT environment correlate with specific fatty acid profiles, gas-chromatographic analysis was carried out on WAT collected from all subject categories. Finally, the effect of the ω3 docosahexaenoic acid treatment on the balance between pro- and anti-inflammatory factors in adipocytes was also evaluated. RESULTS: We provide the first evidence for the existence of a pro-inflammatory environment in WAT of CRC patients, as assessed by the up-regulation of STAT3, and the concomitant decrease of PPARγ and adiponectin with respect to healthy subjects. WAT inflammatory status was independent of obesity degree but correlated with a decreased ω3-/ω6-polyunsaturated fatty acid ratio. These observations suggested that qualitative changes, other than quantitative ones, in WAT fatty acid may influence tissue dysfunctions potentially linked to inflammatory conditions. This hypothesis was further supported by the finding that adipocyte treatment with docosahexaenoic acid restored the equilibrium between STAT3 and PPARγ. CONCLUSION: Our results suggest that adipocyte dysfunctions occur in CRC patients creating a pro-inflammatory environment that might influence cancer development. Furthermore, the protective potential of docosahexaenoic acid in re-establishing the equilibrium between pro- and anti-inflammatory factors might represent a useful tool for preventive and therapeutic strategies.
format Online
Article
Text
id pubmed-3792028
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37920282013-10-10 ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients D’Archivio, Massimo Scazzocchio, Beatrice Giammarioli, Stefania Fiani, Maria L. Varì, Rosaria Santangelo, Carmela Veneziani, Augusto Iacovelli, Annunziata Giovannini, Claudio Gessani, Sandra Masella, Roberta PLoS One Research Article OBJECTIVE: The aim of this study was to correlate specific fatty acid profiles of visceral white adipose tissue (WAT) with inflammatory signatures potentially associated with colorectal cancer (CRC). METHODS: Human adipocytes were isolated from biopsies of visceral WAT from 24 subjects subdivided in four groups: normal-weight (BMI 22.0-24.9 Kg/m(2)) and over-weight/obese (BMI 26.0-40.0 Kg/m(2)), affected or not by CRC. To define whether obesity and/or CRC affect the inflammatory status of WAT, the activation of the pro-inflammatory STAT3 and the anti-inflammatory PPARγ transcription factors as well as the expression of adiponectin were analyzed by immunoblotting in adipocytes isolated from each group of subjects. Furthermore, to evaluate whether differences in inflammatory WAT environment correlate with specific fatty acid profiles, gas-chromatographic analysis was carried out on WAT collected from all subject categories. Finally, the effect of the ω3 docosahexaenoic acid treatment on the balance between pro- and anti-inflammatory factors in adipocytes was also evaluated. RESULTS: We provide the first evidence for the existence of a pro-inflammatory environment in WAT of CRC patients, as assessed by the up-regulation of STAT3, and the concomitant decrease of PPARγ and adiponectin with respect to healthy subjects. WAT inflammatory status was independent of obesity degree but correlated with a decreased ω3-/ω6-polyunsaturated fatty acid ratio. These observations suggested that qualitative changes, other than quantitative ones, in WAT fatty acid may influence tissue dysfunctions potentially linked to inflammatory conditions. This hypothesis was further supported by the finding that adipocyte treatment with docosahexaenoic acid restored the equilibrium between STAT3 and PPARγ. CONCLUSION: Our results suggest that adipocyte dysfunctions occur in CRC patients creating a pro-inflammatory environment that might influence cancer development. Furthermore, the protective potential of docosahexaenoic acid in re-establishing the equilibrium between pro- and anti-inflammatory factors might represent a useful tool for preventive and therapeutic strategies. Public Library of Science 2013-10-07 /pmc/articles/PMC3792028/ /pubmed/24116229 http://dx.doi.org/10.1371/journal.pone.0077432 Text en © 2013 D'Archivio et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
D’Archivio, Massimo
Scazzocchio, Beatrice
Giammarioli, Stefania
Fiani, Maria L.
Varì, Rosaria
Santangelo, Carmela
Veneziani, Augusto
Iacovelli, Annunziata
Giovannini, Claudio
Gessani, Sandra
Masella, Roberta
ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients
title ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients
title_full ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients
title_fullStr ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients
title_full_unstemmed ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients
title_short ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients
title_sort ω3-pufas exert anti-inflammatory activity in visceral adipocytes from colorectal cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792028/
https://www.ncbi.nlm.nih.gov/pubmed/24116229
http://dx.doi.org/10.1371/journal.pone.0077432
work_keys_str_mv AT darchiviomassimo ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients
AT scazzocchiobeatrice ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients
AT giammariolistefania ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients
AT fianimarial ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients
AT varirosaria ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients
AT santangelocarmela ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients
AT venezianiaugusto ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients
AT iacovelliannunziata ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients
AT giovanniniclaudio ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients
AT gessanisandra ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients
AT masellaroberta ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients